Category Archives: Parkinson’s Treatment

The first thing Gene Freund did after undergoing an incisionless brain procedure intended to still the tremors in his right hand was reach for a flimsy Styrofoam cup on a hospital side table. Continue reading →

According to an internal document seen byThe Guardian,the NHS is facing significant shortages of a number of lifesaving medicines for the treatment of cancer, heart conditions and epilepsy. The document was sent to doctors from the medicine supply team at the Department of Health and Social Care (DHSC), and allegedly listed various drugs that the NHS is facing shortages of. Continue reading →

New research by Fior Markets gives complete guidance which covers the most recent Parkinsons Disease Treatment industry patterns including market development openings, size, share, and development trends. The report specifically focuses on market volume and value at the global level, regional level, and company level. Continue reading →

NEW YORK and BASEL, Switzerland, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that the U.S Continue reading →

As part of a new partnership with Parkinsons UK, the Parkinsons Foundation has granted the nonprofit $250,000 toward a prospective new treatmentlinked to mitochondrial function that is being developed in the Parkinsons Virtual Biotech program. The grant will help advance a project aimed at uncovering new methods of potentially impeding brain cell death through stabilization of the source of energy necessary for cell survival the mitochondria. Continue reading →

I dont want to take away from Mad magazines Alfred E. Neuman or singer-songwriter Bobby McFerrin, but the idea that a pair of rose-colored dont worry glasses will change my life for the better has never sat well with me Continue reading →

Earlier onset of disease, early impairment of memory and thinking, and higher daily use of antiparkinson medication, are associated with increased risk of death related to Parkinsons disease (PD), according to a study that followed newly diagnosed patients for more than 10 years. Conversely, being male, the severity of disease symptoms, and general cognitive ability do not seem to contribute significantly to Parkinsons-related mortality. The study, Overall and Disease Related Mortality in Parkinsons Disease a Longitudinal Cohort Study, was published in the Journal of Parkinsons Disease. Continue reading →

Parkinsons disease is a progressive neurodegenerative disorder affecting one in 350 Australians. Its caused by the loss of cells deep within the brain that produce a neurotransmitter called dopamine. Continue reading →

A surgeon has implanted electrodes in the brain of a patient suffering from severe opioid use disorder, hoping to cure the mans intractable craving for drugs. The device, known as a deep brain stimulator, is designed to alter the function of circuits in the brain. It has been used with varying degrees of success in the treatment of Parkinsons disease, dystonia, epilepsy, obsessive-compulsive disorder and even depression Continue reading →

You may have encountered the term rainmaker used in the nonliteral sense. Lindsay McPhail, editorial director of The Wild Woman Magazine, describes a rainmaker as someone who brings hope to dry and barren places Continue reading →